Skip to main content
OpenTrials

Clinical trial condition

Breast Diseases

Explore clinical trials studying Breast Diseases. Study availability and eligibility vary by location and protocol.

103 public trials 17 recruiting studies
Refine in advanced search Browse all conditions

Breast Diseases trial results

Active, Not Recruiting

Trastuzumab Deruxtecan (T-DXd) With or Without Pertuzumab Versus Taxane, Trastuzumab and Pertuzumab in HER2-positive Metastatic Breast Cancer (DESTINY-Breast09)

NCT04784715

Conditions
Breast Cancer; HER2-positive; Metastatic, Breast Diseases, Breast Neoplasms, +8 more
Locations
  • Research Site Tucson, Arizona, United States
  • Research Site Springdale, Arkansas, United States
  • Research Site Glendale, California, United States
  • Research Site Glendale, California, United States
View all 283 locations
View Trial Details
Active, Not Recruiting

Phase III Study to Assess AZD9833+ CDK4/6 Inhibitor in HR+/HER2-MBC With Detectable ESR1m Before Progression (SERENA-6)

NCT04964934

Conditions
Breast Diseases, Breast Neoplasms, ER-Positive HER2-Negative Breast Cancer, +8 more
Locations
  • Research Site Phoenix, Arizona, United States
  • Research Site Hot Springs, Arkansas, United States
  • Research Site Little Rock, Arkansas, United States
  • Research Site Long Beach, California, United States
View all 264 locations
View Trial Details
Active, Not Recruiting

A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations

NCT07038369

Conditions
Adnexal Diseases, Advanced Solid Tumors, Breast Cancer, +46 more
Locations
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Florida Cancer Specialists & Research Institute - Lake Mary Lake Mary, Florida, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Washington University St Louis, Missouri, United States
View Trial Details
Active, Not Recruiting

Robotic vs. Open NSM for Early Stage Breast Cancer

NCT05720039

Conditions
Breast, Breast Cancer, Breast Cancer Female, +8 more
Locations
  • City of Hope Irvine, California, United States
  • Cedars-Sinai Los Angeles, California, United States
  • Mayo Clinic Florida Jacksonville, Florida, United States
  • Emory University Atlanta, Georgia, United States
View all 15 locations
View Trial Details
Active, Not Recruiting

A Comparative Study of AZD9833 Plus Palbociclib Versus Anastrozole Plus Palbociclib in Patients With ER-Positive HER2 Negative Breast Cancer Who Have Not Received Any Systemic Treatment for Advanced Disease

NCT04711252

Conditions
Breast Diseases, Breast Neoplasms, ER-Positive HER2-Negative Breast Cancer, +8 more
Locations
  • Research Site Mobile, Alabama, United States
  • Research Site Springdale, Arkansas, United States
  • Research Site Harbor City, California, United States
  • Research Site Solvang, California, United States
View all 263 locations
View Trial Details
Active, Not Recruiting

Anastrozole, Palbociclib, Trastuzumab and Pertuzumab in HR-positive, HER2-positive Metastatic Breast

NCT03304080

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +3 more
Locations
  • Mount Sinai Beth Israel Comprehensive Cancer Center West New York, United States
  • Perlmutter Cancer Center NYU Langone New York, United States
  • Mount Sinai West New York, United States
  • New York Presbyterian Columbia Irving Comprehensive Cancer Center New York, United States
View Trial Details

Related conditions